Progenics Pharmaceuticals

PGNX

PGNX
Progenics Pharmaceuticals Stock Quote
$5.06 $0.21 4.3%
BATS BZX Real Time Price as of October 21, 2019, 4:00 p.m. EDT View Interactive PGNX Charts

A biopharmaceutical company focusing on the development and commercialization of innovative therapeutic products to treat the unmet medical needs of patients with debilitating conditions and life-threatening diseases.

News & Analysis: Progenics Pharmaceuticals

The Fool has written over 100 articles on Progenics Pharmaceuticals.

All

Market Moves

Earnings











Interactive Chart